Edward H. Levine
Author pages are created from data sourced from our academic publisher partnerships and public sources.
A randomized trial of exercise on well-being and function following breast cancer surgery: the RESTORE trial
ObjectivesThis study aimed to determine the effect of a moderate, tailored exercise program on health-related quality of life, physical function, and arm volume in women receiving treatment for… Expand
Elevation of serum riboflavin carrier protein in breast cancer.
- P. N. Rao, E. Levine, +7 authors M. Raj
- Cancer epidemiology, biomarkers & prevention : a…
- 1 November 1999
Presently available tumor markers have had a limited clinical impact. Riboflavin carrier protein (RCP) is an estrogen inducible protein that occupies a key position in riboflavin metabolism. Because… Expand
Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study.
- C. Denysschen, H. Burton, F. Ademuyiwa, E. Levine, Sheldon Tetewsky, T. O'connor
- European journal of cancer care
- 1 July 2014
Aromatase inhibitors (AIs) block estrogen synthesis and are commonly used as adjuvant treatments for breast cancer patients. A common side effect is joint pain. This was a pilot study to examine… Expand
Abdominal pain and colonic obstruction from an intra-abdominal desmoid tumor.
Desmoid tumors are rare, benign, slow-growing, fibroblastic neoplasms that originate from musculoaponeurotic and fascial structures throughout the body. These tumors do not have the ability to… Expand
A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer
- T. O'connor, Y. Rustum, E. Levine, P. Creaven
- Cancer Chemotherapy and Pharmacology
- 11 April 2007
PurposeThere is a need for chemotherapy regimens active against anthracycline- and taxane-refractory breast cancer. Data from preclinical and pilot studies performed at Roswell Park Cancer Institute… Expand
Phase II Trial of Induction Gemcitabine/CPT-11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer
- G. Mishra, J. Butler, +9 authors A. W. Blackstock
- American journal of clinical oncology
- 1 August 2005
Purpose:This phase II trial of induction irinotecan/gemcitabine followed by twice-weekly gemcitabine and upper abdominal radiation was initiated to determine the activity of this regimen in patients… Expand
Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration.
BACKGROUND Telomerase activity is up-regulated in pancreatic cancer. Hence, measurement of telomerase activity in pancreatic needle-biopsy specimens could assist in establishing a positive diagnosis… Expand
Elevation of serum riboflavin carrier protein in hepatocellular carcinoma.
- P. Rao, J. Crippin, +6 authors M. G. Raj
- Hepatology research : the official journal of the…
- 1 June 2006
Early detection of hepatocellular cancer (HCC), makes it surgically resectable with a potential for cure. The test most commonly used to detect HCC is the measurement of serum alpha-fetoprotein (AFP)… Expand
Phase I study of paclitaxel and carboplatin: implications for trials in head and neck cancer.
An ongoing phase I and pharmacokinetic trial of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) in combination with carboplatin is evaluating the maximum tolerated dose (MTD) of a… Expand
Irinotecan/gemcitabine followed by twice-weekly gemcitabine/radiation in locally advanced pancreatic cancer.
Early clinical studies combining irinotecan (CPT-11, Camptosar) and gemcitabine (Gemzar) have yielded encouraging results. Gemcitabine administered via a twice-weekly schedule results in an enhanced… Expand